VitalStone Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

VitalStone Financial’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-62	Closed	–	–	686
2023 Q2	$0	Buy	+62	New	–	﹤0.01%	1083

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.19B AUM 34.45% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

VitalStone Financial's SRNE Position: Q3 2023 in Review

VitalStone Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2023, closing a stake of 62 shares.

VitalStone Financial first reported a position in SRNE in Q2 2023 and held it in 1 quarter. The position peaked at $0 in Q2 2023. 9 funds tracked by Wall St. Rank hold SRNE as of Q3 2023.

VitalStone Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
VitalStone Financial sold 62 Sorrento Therapeutics, Inc. shares in Q3 2023.
VitalStone Financial first reported a position in Sorrento Therapeutics, Inc. in Q2 2023 and held it in 1 quarter.
VitalStone Financial's Sorrento Therapeutics, Inc. position peaked at $0 in Q2 2023.
9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2023.

Based on VitalStone Financial's 13F filing for Q3 2023, filed 15 Nov 2023.